Sanofi, GSK to seek COVID-19 vaccine candidate approval
French drugmaker Sanofi and its British partner GlaxoSmithKline said on Wednesday they intend to submit data from their booster and Phase III efficacy trials as the basis for regulatory applications for a COVID-19 vaccine.